Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 76 AL 90

PUBMED

Drosophila eye color mutants as therapeutic tools for Huntington disease.

Green EW, Campesan S, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, Kyriacou CP, Giorgini F.

Fly (Austin). 2012 Apr-Jun;6(2):117-20. doi: 10.4161/fly.19999.

0

0

0

PUBMED

Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

Unschuld PG, Joel SE, Pekar JJ, Reading SA, Oishi K, McEntee J, Shanahan M, Bakker A, Margolis RL, Bassett SS, Rosenblatt A, Mori S, van Zijl PC, Ross CA, Redgrave GW.

Psychiatry Res. 2012 Aug-Sep;203(2-3):166-74. doi: 10.1016/j.pscychresns.2012.01.002.

0

0

0

PUBMED

Beyond the patient: the broader impact of genetic discrimination among individuals at risk of Huntington disease.

Bombard Y, Palin J, Friedman JM, Veenstra G, Creighton S, Bottorff JL, Hayden MR; Canadian Respond-HD Collaborative Research Group..

Am J Med Genet B Neuropsychiatr Genet. 2012 Mar;159B(2):217-26. doi: 10.1002/ajmg.b.32016.

0

0

0

PUBMED

Huntington disease and the huntingtin protein.

Zheng Z, Diamond MI.

Prog Mol Biol Transl Sci. 2012;107:189-214. doi: 10.1016/B978-0-12-385883-2.00010-2. Review.

0

0

0

PUBMED

Sarah Tabrizi: tracking Huntington's disease.

Shetty P.

Lancet. 2012 Jun 2;379(9831):2043. doi: 10.1016/S0140-6736(12)60884-8. No abstract available.

0

0

0

PUBMED

Does Huntington's disease enhance cephalad spread during neuraxial anesthesia for cesarean section?

Draisci G, Sbaraglia F, Pinto R, Zanfini BA, Frassanito L, Catarci S.

J Clin Anesth. 2012 Sep;24(6):516-7. doi: 10.1016/j.jclinane.2011.09.011. No abstract available.

0

0

0

PUBMED

ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington's disease.

Lee J, Hong YK, Jeon GS, Hwang YJ, Kim KY, Seong KH, Jung MK, Picketts DJ, Kowall NW, Cho KS, Ryu H.

Cell Death Differ. 2012 Jul;19(7):1109-16. doi: 10.1038/cdd.2011.196.

0

0

0

PUBMED

Multiple phenotypes in Huntington disease mouse neural stem cells.

Ritch JJ, Valencia A, Alexander J, Sapp E, Gatune L, Sangrey GR, Sinha S, Scherber CM, Zeitlin S, Sadri-Vakili G, Irimia D, Difiglia M, Kegel KB.

Mol Cell Neurosci. 2012 May;50(1):70-81. doi: 10.1016/j.mcn.2012.03.011.

0

0

0

PUBMED

Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells.

Feyeux M, Bourgois-Rocha F, Redfern A, Giles P, Lefort N, Aubert S, Bonnefond C, Bugi A, Ruiz M, Deglon N, Jones L, Peschanski M, Allen ND, Perrier AL.

Hum Mol Genet. 2012 Sep 1;21(17):3883-95. doi: 10.1093/hmg/dds216.

0

0

0

PUBMED

Witchcraft and Huntington's disease: a salutary history of societal and medical stigmatisation.

Loi S, Chiu E.

Australas Psychiatry. 2012 Oct;20(5):438-41. doi: 10.1177/1039856212459587.

0

0

0

PUBMED

NGF and nitrosative stress in patients with Huntington's disease.

Tasset I, Sánchez-López F, Agüera E, Fernández-Bolaños R, Sánchez FM, Cruz-Guerrero A, Gascón-Luna F, Túnez I.

J Neurol Sci. 2012 Apr 15;315(1-2):133-6. doi: 10.1016/j.jns.2011.12.014.

0

0

0

PUBMED

Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease.

Kumar A, Kneynsberg A, Tucholski J, Perry G, van Groen T, Detloff PJ, Lesort M.

Exp Neurol. 2012 Sep;237(1):78-89. doi: 10.1016/j.expneurol.2012.05.015.

0

0

0

PUBMED

The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?

Schipper-Krom S, Juenemann K, Reits EA.

Biochem Res Int. 2012;2012:837015. doi: 10.1155/2012/837015.

0

0

0

PUBMED

Substance abuse may be a risk factor for earlier onset of Huntington disease.

Byars JA, Beglinger LJ, Moser DJ, Gonzalez-Alegre P, Nopoulos P.

J Neurol. 2012 Sep;259(9):1824-31. doi: 10.1007/s00415-012-6415-8.

0

0

0

PUBMED

Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.

Tsai YC, Metzger S, Riess O, Soehn AS, Nguyen HP.

BMC Med Genet. 2012 Jun 21;13:48. doi: 10.1186/1471-2350-13-48.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy